This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Clsn Laboratories, Inc., Egen, Inc., Other. Active years: 2001-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Milwaukee, WI (US) (2001)
- Mosheim, TN (US) (2010)
- Huntsville, AL (US) (2013 - 2016)
Company Filing History:
3 out of 6 
1 out of 8 
2 out of 834,513 Years Active: 2001-2016
Title: The Innovative Contributions of Brian Jeffery Sparks
Introduction: Brian Jeffery Sparks, based in Huntsville, Alabama, is a notable inventor with a remarkable portfolio featuring four patents. His work primarily revolves around the development of polyamine derivatives and their applications in delivering biologically active molecules effectively.
Latest Patents: Among Brian's most significant contributions are his latest inventions focusing on polyamine derivatives. He has disclosed various compounds, compositions, and methods aimed at the systemic and local delivery of biologically active molecules. This innovative approach signifies a notable advancement in drug delivery systems, showcasing his dedication to improving health-related technologies.
Career Highlights: Brian has made substantial impacts throughout his professional journey. He has worked with prominent companies such as CLSN Laboratories, Inc. and Egen, Inc. His experiences in these organizations have undoubtedly enriched his expertise and have been instrumental in the development of his inventions.
Collaborations: Throughout his career, Brian has collaborated with talented professionals, including Gregory Slobodkin and Richard Congo. These collaborations highlight the importance of teamwork in pushing the boundaries of innovation and achieving breakthroughs in various fields.
Conclusion: Brian Jeffery Sparks stands out as a significant figure in the realm of innovation. With his dedication to developing advanced methodologies and his collaborative spirit, he continues to contribute valuable insights to the scientific community. His work not only enhances existing technologies but also paves the way for future advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile